Barclays Trims Privia Health Group (NASDAQ:PRVA) Target Price to $19.00

Privia Health Group (NASDAQ:PRVA – Free Report) had its target price decreased by Barclays from $22.00 to $19.00 in a research report sent to investors on Monday morning, Benzinga reports. Barclays currently has an equal weight rating on the stock. PRVA has been the subject of a number of other reports. Bank of America cut […]

Related Keywords

United States ,America ,David Mountcastle ,Thomas Bartrum ,Vanguard Group Inc ,Privia Health Group Price Performance ,Unisuper Management Pty Ltd ,Jefferies Financial Group ,Analyst Recommendations For Privia Health Group ,Privia Health Group Company Profile ,Bellevue Group ,Privia Health Group Inc ,Covestor Ltd ,First Light Asset Management ,Canaccord Genuity Group ,News Ratings For Privia Health Group Daily ,Barclays ,Securities Exchange Commission ,Privia Health Group ,Free Report ,Financial Group ,Moderate Buy ,Health Group ,Get Free Report ,Exchange Commission ,Light Asset Management ,Super Management Pty Ltd ,Vanguard Group ,Privia Health Group Daily ,